A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PAP / 3-(N-phenylamino)-1,2-propanediol

[Related PubMed/MEDLINE]
Total Number of Papers: 12
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PAP  (>> Co-occurring Abbreviation)
Long Form:   3-(N-phenylamino)-1,2-propanediol
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2007 LC-MS ion maps for the characterization of aniline derivatives of fatty acids and triglycerides in laboratory-denatured rapeseed oil. FAA, TOS
2006 Endocytosis and intracellular trafficking of fatty acid esters of phenylaminopropanediol, the putative etiologic agents of the toxic oil syndrome (TOS). DiI, TOS
2004 Induction of c-fos messenger RNA by 3-(N-phenylamino)-1,2-propanediol esters, compounds related to Toxic Oil Syndrome. TOS
2004 Studies on toxic oil syndrome: stereoselective hydrolysis of 3-(phenylamino)propane-1,2-diol esters by human pancreatic lipase. HPL, TOS
2003 Investigating the onset of autoimmunity in A.SW mice following treatment with 'toxic oils'. TOS
2002 The Spanish toxic oil syndrome 20 years after its onset: a multidisciplinary review of scientific knowledge. TOS
2001 Absorption and effects of 3-(N-phenylamino)-1,2-propanediol esters in relation to toxic oil syndrome. PAF, TOS
2001 Storage time and deodorization temperature influence the formation of aniline-derived compounds in denatured rapeseed oils. ---
1999 The acute pathology of fatty acid anilides and linoleic diester of 3-phenylamino-1,2-propanediol in mice: possible implication as aetiologic agents for the toxic oil syndrome. TOS
10  1997 Effects of 3-phenylamino-1,2-propanediol and its mono- and dioleylesters on the production of reactive oxygen metabolites in human polymorphonuclear leukocytes. PMA, PMNL, ROM
11  1995 A comparison of the acute pathology induced by 3-phenylamino-1,2-propanediol (PAP) and its mono-oleoyl ester in rodents with the toxic oil syndrome in man. TOS
12  1995 Possible etiologic agents for toxic oil syndrome: fatty acid esters of 3-(N-phenylamino)-1,2-propanediol. DEPAP, TOS